Nexthera Capital’s Pfizer PFE Stock Holding History

Nexthera Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-126,480	Closed	-$5.29M	–	39
2018 Q3	$5.29M	Buy	+126,480	New	+$4.87M	1.01%	27

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nexthera Capital's PFE Position: Q3 2017 in Review

Nexthera Capital sold out of Pfizer (PFE) in Q3 2017, closing a stake of 368,932 shares — an estimated $11.8M sold.

Nexthera Capital first reported a position in PFE in Q4 2015 and held it in 7 quarters. The position peaked at $26.9M in Q1 2017. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

Nexthera Capital reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
Nexthera Capital sold 368,932 Pfizer shares in Q3 2017, an estimated $11.8M.
Nexthera Capital first reported a position in Pfizer in Q4 2015 and held it in 7 quarters.
Nexthera Capital's Pfizer position peaked at $26.9M in Q1 2017.
2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Nexthera Capital's 13F filing for Q3 2017, filed 14 Nov 2017.